Aprameya Engineering made a strong market debut with its share price opening at ₹72 on the NSE SME, marking a 24.14% premium over its issue price of ₹58. This impressive start reflects robust investor enthusiasm for the stock.
Aprameya Engineering IPO witnessed tremendous interest, achieving a subscription rate of 179.08 times by Day 3. This impressive response highlights strong investor confidence and enthusiasm for the company’s growth prospects and its standing in the industry.
Aprameya Engineering Limited, specialising in healthcare infrastructure, installs and maintains ICUs, NICUs, PICUs, and operation theatres. Since 2020, it has installed 2000 critical care beds in Rajasthan’s government hospitals, driving 201% revenue growth from 2021 to 2023 through high-value medical equipment and experienced management.
Aprameya Engineering Ltd’s IPO aims to raise INR 28.73 crores for working capital needs, enhancing profitability, unlocking internal accruals, supporting growth, and funding general corporate purposes, including expansion and brand building.